NewsRoom Articles - Page 187 of 241

WednesdayMay 19, 2021 11:14 am

New Study Links Neurodegenerative Diseases to Gut Bacteria Changes

New research done by a team from the University of Florida has uncovered evidence that links the manifestation of neurodegenerative diseases such as Parkinson’s, Alzheimer’s and ALS to the presence of specific bacteria types in the gut. Previous research had pointed to gut microbiota changes in people who suffered from neurodegenerative conditions. However, the huge diversity of bacteria in the digestive tract made it a daunting task to pinpoint the specific bacteria types connected to neurodegenerative diseases. This is the challenge that the University of Florida team took head on. Rather than study the gut microorganisms of humans, the researchers…

TuesdayMay 18, 2021 3:09 pm

Leukemia Treatment Could Lie in Avocado Compound

Like many other types of cancer, leukemia currently has no cure. Although treatments are largely dependent on whether the cancer is slow growing or aggressive, most of the treatments are pretty toxic and, in extreme cases, can even cost the patients their lives. There are several types of leukemia, and researchers from the University of Guelph may have found a way to cure one of the most devastating forms of cancer, acute myeloid leukemia (“AML”). AML often afflicts people over the age of 65 and has quite a low survival rate; less than 10% of patients live for more than…

TuesdayMay 18, 2021 1:46 pm

RYAH Group, Inc. (CSE: RYAH) Enters New Zealand Market

A partnership with Medical Kiwi LTD makes it possible for RYAH to enter the New Zealand Market Medical Kiwi was the first South Island-based company to be granted a Medicinal Cannabis license from the Ministry of Health to cultivate The potential market for medical cannabis in New Zealand is at NZ$1.5 billion RYAH Group (CSE: RYAH), a health care analytics and technology company, has entered the New Zealand market through a definitive wholesale supply and distribution agreement with Medical Kiwi LTD (https://ibn.fm/jN4T7). This agreement enables RYAH’s suite of IoT devices and cloud-based data analytics to be used in pre-clinical and…

TuesdayMay 18, 2021 1:30 pm

Predictive Oncology Inc. (NASDAQ: POAI) Appoints Venture Investor Dr. Christina Jenkins to Board of Directors

POAI appoints strategic advisor, venture investor Dr. Christina Jenkins to board of directors Dr. Jenkins’ experience spans work in capital markets, clinical medicine, public healthcare systems Other roles include current Board Director for Independence Health Group, Venture Partner at Phoenix Venture Partners, Board Observer for Madorra Inc., board advisory roles at multiple value-generating healthcare companies Past experience includes role as founding CEO of OneCity Health Services, subsidiary of NYC Health + Hospitals Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently appointed strategic advisor and venture investor Dr. Christina…

TuesdayMay 18, 2021 1:02 pm

Brain Scientific Inc. (BRSF) Featured in Med-Tech News as Technology Provider Revolutionizing Pediatric Brain Diagnostics

BRSF featured in industry publication as a company that transforms EEG testing in children, cutting procedure time from 30 to as little as 5 minutes. The need for brain diagnostics in children is on the rise, but supply and availability of EEG testing to pediatric physicians remains limited. BRSF has stepped in to fill the gap in unmet patients' needs; positioning itself as a leading innovator in this field. Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, was featured in Med-Tech News, a publication covering medical devices medical manufacturing, as a Company revolutionizing the space of pediatric…

TuesdayMay 18, 2021 9:15 am

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Targets Potential Expansion of Rapid COVID-19 Test Kit Distribution with Delivery of 2,000 Units to Israel

XPhyto recently delivered 2,000 of its rapid Covid-ID Lab test kits to an established Israeli distributor for clinical evaluation by the Ministry of Health The delivery, which marks entry into the Middle East, follows the approval of the test kits in Europe In an earlier interview, CEO Hugh Rogers had noted that XPhyto was looking to expand distribution to various markets, including the Middle East In an interview on Proactive on March 22, XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) CEO and Director Hugh Rogers explained the implications of the CE-IVD approval (European certification) the company’s 25-minute COVID-19 RT-PCR…

TuesdayMay 18, 2021 9:00 am

Healthy Extracts Inc. (HYEX) Is Well-Positioned To Capitalize The Growing Demand Of The Nutraceuticals Products Market

Healthy Extracts Inc. through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”) is focused on building a stronghold in the nutraceuticals market BergaMet NA is the only company authorized to manufacture, distribute, and sell Citrus Bergamot SuperFruit(TM) in North America, a supplement enriched with the world’s best quality polyphenols and flavonoids BergaMet North America’s HERHEART(TM) is a natural supplement, scientifically formulated to support woman’s cardiovascular health, as well as managing perimenopausal symptoms Healthy Extracts (OCTQB: HYEX) through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”) is focused on the proprietary research, development, and sale of natural…

MondayMay 17, 2021 2:15 pm

Sleep Disorders Cost the US $95 Billion Annually, Study Finds

We spend a large chunk of our lifetimes asleep — the average person spends around 26 years of their life snoozing, and all this sleep has a major impact on our bodies. Not only does sleep allow us to replenish and recharge after a tiring day, but it is also the time when the body purges itself of toxic waste, repairs cells, and releases useful molecules such as proteins and hormones. If you consistently fail to get enough quality sleep, you greatly increase your risk of getting medical conditions such as diabetes, high blood pressure, heart attack, heart failure or…

MondayMay 17, 2021 9:00 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology, will Potentially Reduce High Bladder Cancer Recurrence Rates

Approximately 50% of patients who have bladder cancer will see a recurrence of the condition – often due to poor margin visibility White light has been the standard procedure during cystoscopies, but is only beneficial if tumors protrude from the bladder wall Blue light cystoscopies address this issue, increasing the odds of removing more cancerous cells and reducing the recurrence of the cancer The i/Blue Imaging System(TM) improves surgical technique by combining both white and blue light capabilities on one screen without the necessity of switching between two images Imagin Medical Inc. is currently moving toward commercializing the system, expecting…

FridayMay 14, 2021 2:50 pm

An Infant’s First Stool May Be Used to Predict Their Future Health

A recent study by a group of researchers from the University of British Columbia has found that the composition of meconium can be used to find out whether a baby will develop allergies as they get older. Meconium, which is a child’s first poop, is a thick dark-green substance. The research was reported in the Cell Reports Medicine journal. Dr. Brett Finlay, a professor from the university’s departments of immunology, microbiology, molecular biology and biochemistry, explained that the analysis they conducted showed that compared with babies who didn’t develop allergic sensitization, those who did had considerably less rich meconium after…